Patent 9744179 was granted and assigned to Rempex Pharmaceuticals on August, 2017 by the United States Patent and Trademark Office.
The present invention relates to compositions, pharmaceutical compositions, and methods for preparing the same, comprising a tetracycline with improved stability and solubility. Some embodiments include a tetracycline with an excess of a divalent or trivalent cation.